Filana Therapeutics, Inc. (FLNA)
$0.82+1.23%Close
BUYCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $40M
- Beta
- -0.66
- P/E (TTM)
- -1.01
- Short % float
- 12.44%
- Days to cover
- 1.0
- SI change
- -5.3%
- 1W
- -11.83%
- 1M
- +1.23%
- vs SPY 1W
- -12.99%
- vs SPY 1M
- -1.76%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on FLNA?
- LOPJLB’s latest quantitative signal on Filana Therapeutics, Inc. (FLNA) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is FLNA in?
- Filana Therapeutics, Inc. (FLNA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Filana Therapeutics, Inc. (FLNA) do?
- Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.